M1774
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for M1774, covering 2026-01-07 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer [Phase 2]